Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Canada Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20035
20044
20054
20067
20076
20083
20092
20101
20121
20132
20145
20152
20172
20183
20191
20201
20211
20223
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated8
Recruiting4
Unknown status3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi9
Population Health Research Institute6
Astellas Pharma Inc3
Boehringer Ingelheim3
Montreal Heart Institute3
Advanz Pharma2
Bayer2
Bristol-Myers Squibb2
Daiichi Sankyo2
Forest Laboratories2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation61
Stroke14
Arrhythmias, Cardiac8
Atrial Flutter8
Heart Failure4
Hemorrhage4
Thromboembolism4
Heart Diseases3
Acute Coronary Syndrome2
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.